Chengwei Capital
Anti-tumour Drug Developer Tot Biopharm Files For Hong Kong IPO
Business - Published date: .
Tot Biopharm, a Suzhou-headquartered biotechnology firm backed by Chengwei Capital, has filed to list in Hong Kong unde... Read more
Anti-tumour Drug Developer Tot Biopharm Files For Hong Kong IPO
Business - Published date: .
Tot Biopharm, a Suzhou-headquartered biotechnology firm backed by Chengwei Capital, has filed to list in Hong Kong unde... Read more